Structural dynamic analysis of apo and ATP-bound IRAK4 kinase

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Gosu, Vijayakumar ^a   Choi, Sangdun ^a  

^a Ajou University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOENZYME; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK4 PROTEIN, HUMAN; MAGNESIUM; PROTEIN BINDING;

CHEMISTRY; ENZYME ACTIVE SITE; HUMAN; MOLECULAR DYNAMICS; PROTEIN SECONDARY STRUCTURE;

ADENOSINE TRIPHOSPHATE; APOENZYMES; CATALYTIC DOMAIN; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MAGNESIUM; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY;

EID: 84904626297     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05748     Document Type: Article

References (83)

1. Akira, S.,akeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511 (2004). (Pubitemid 38931765)
2. Akira, S. TLR signaling. Curr. Top. Microbiol. Immunol. 311, 1-16 (2006). (Pubitemid 47413193)
3. O'Neill, L. A., Bryant, C. E. & Doyle, S. L. Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol. Rev. 61, 177-197 (2009).
4. Makkouk, A. & Abdelnoor, A. M. The potential use of Toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents. Immunopharmacol. Immunotoxicol. 31, 331-338 (2009).
5. Gosu, V., Basith, S., Kwon, O. P. & Choi, S. Therapeutic applications of nucleic acids and their analogues in Toll-like receptor signaling. Molecules 17, 13503-13529 (2012).
6. Wang, Z.,Wesche, H., Stevens, T.,Walker, N. & Yeh, W. C. IRAK-4 inhibitors for inflammation. Curr. Top. Med. Chem. 9, 724-737 (2009).
7. Janssens, S. & Beyaert, R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11, 293-302 (2003). (Pubitemid 36293825)
8. Gosu, V., Basith, S., Durai, P. & Choi, S. Molecular evolution and structural features of IRAK family members. PLoS One 7, e49771 (2012).
9. Medzhitov, R. et al.MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2, 253-258 (1998). (Pubitemid 128373651)
10. Fitzgerald, K. A. et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78-83 (2001). (Pubitemid 32843491)
11. Martin, M. U. & Wesche, H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim. Biophys. Acta. 1592, 265-280 (2002). (Pubitemid 35284883)
12. Kobayashi, K. et al. IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling. Cell 110, 191-202 (2002). (Pubitemid 34876547)
13. Brikos, C.,Wait, R., Begum, S., O'Neill, L. A. J. & Saklatvala, J. Mass Spectrometric Analysis of the Endogenous Type I Interleukin-1 (IL-1) Receptor Signaling Complex Formed after IL-1 Binding Identifies IL-1RAcP, MyD88, and IRAK-4 as the Stable Components. Mol. Cell. Proteomics 6, 1551-1559 (2007). (Pubitemid 47506166)
14. Li, S., Strelow, A., Fontana, E. J. & Wesche, H. IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. U. S. A. 99, 5567-5572 (2002). (Pubitemid 34411589)
15. Suzuki, N. et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416, 750-756 (2002).
16. Picard, C. et al. Pyogenic Bacterial Infections in Humans with IRAK-4 Deficiency. Science 299, 2076-2079 (2003). (Pubitemid 36383736)
17. Medvedev, A. E. et al. Cutting edge: Expression of IL-1 receptor-associated kinase-4 (IRAK-4) proteins with mutations identified in a patient with recurrent bacterial infections alters normal IRAK-4 interaction with components of the IL-1 receptor complex. J. Immunol. 174, 6587-6591 (2005). (Pubitemid 40705618)
18. Ku, C. L. et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204, 2407-2422 (2007).
19. Ku, C. L. et al. Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol. Rev. 203, 10-20 (2005).
20. Lye, E., Mirtsos, C., Suzuki, N., Suzuki, S. & Yeh, W. C. The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling. J. Biol. Chem. 279, 40653-40658 (2004). (Pubitemid 39287659)
21. Koziczak-Holbro, M. et al. IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor-and toll-like receptor 7-mediated signaling and gene expression. J. Biol. Chem. 282, 13552-13560 (2007). (Pubitemid 47100553)
22. Koziczak-Holbro, M. et al. Solving the IRAK-4 enigma: Application of kinase-dead knock-in mice. Ernst Schering Found. Symp. Proc. 3, 63-82 (2007).
23. Kim, T. W. et al. A critical role for IRAK4 kinase activity in Toll-like receptormediated innate immunity. J. Exp. Med. 204, 1025-1036 (2007).
24. Lye, E., Dhanji, S., Calzascia, T., Elford, A. R. & Ohashi, P. S. IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses. Eur. J. Immunol. 38, 870-876 (2008).
25. Yang, K. et al. Human TLR-7-,-8-, and-9-mediated induction of IFN-alpha/beta and-lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 23, 465-478 (2005). (Pubitemid 41587887)
26. Isnardi, I. et al. IRAK-4-and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 29, 746-757 (2008).
27. Barrat, F. J., Meeker, T., Chan, J. H., Guiducci, C. & Coffman, R. L. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur. J. Immunol. 37, 3582-3586 (2007).
28. Sun, M., Yang, P., Du, L., Yang, Y. & Ye, J. The role of interleukin-1 receptorassociated kinases in Vogt-Koyanagi-Harada disease. PLoS One 9, e93214 (2014).
29. Cao, Z., Henzel, W. J. & Gao, X. IRAK: A kinase associated with the interleukin-1 receptor. Science 271, 1128-1131 (1996). (Pubitemid 26075229)
30. Muzio, M. IRAK (Pelle) Family Member IRAK-2 and MyD88 as Proximal Mediators of IL-1 Signaling. Science 278, 1612-1615 (1997). (Pubitemid 27516277)
31. Wesche, H. et al. IRAK-M is a novel member of the Pelle/interleukin-1 receptorassociated kinase (IRAK) family. J. Biol. Chem. 274, 19403-19410 (1999).
32. Wang, Z. et al. Crystal Structures of IRAK-4 Kinase in Complex with Inhibitors: A Serine/Threonine Kinase with Tyrosine as a Gatekeeper. Structure 14, 1835-1844 (2006). (Pubitemid 44855630)
33. Cheng, H. et al. Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop. Biochem. Biophys. Res. Commun. 352, 609-616 (2007). (Pubitemid 44880298)
34. Kuglstatter, A. et al. Cutting Edge: IL-1 receptor-associated kinase 4 structures reveal novel features and multiple conformations. J. Immunol. 178, 2641-2645 (2007). (Pubitemid 46333138)
35. Johnson, L. N. & Lewis, R. J. Structural basis for control by phosphorylation. Chem. Rev. 101, 2209-2242 (2001). (Pubitemid 35373017)
36. Nolen, B., Taylor, S. & Ghosh, G. Regulation of protein kinases; controlling activity through activation segment conformation. Mol. Cell 15, 661-675 (2004). (Pubitemid 39194898)
37. De Bondt, H. L. et al. Crystal structure of cyclin-dependent kinase 2. Nature 363, 595-602 (1993). (Pubitemid 23227617)
38. Goldberg, J., Nairn, A. C. & Kuriyan, J. Structural basis for the autoinhibition of calcium/calmodulin-dependent protein kinase I. Cell 84, 875-887 (1996). (Pubitemid 26106857)
39. Sicheri, F., Moarefi, I. & Kuriyan, J. Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609 (1997). (Pubitemid 27087567)
40. Xu, W., Harrison, S. C. & Eck, M. J. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602 (1997). (Pubitemid 27087566)
41. Gan, W., Yang, S. & Roux, B. Atomistic view of the conformational activation of Src kinase using the string method with swarms-of-trajectories. Biophys.J. 97, L8-L10 (2009).
42. Berteotti, A. et al. Protein conformational transitions: the closure mechanism of a kinase explored by atomistic simulations. J. Am. Chem. Soc. 131, 244-250 (2009).
43. Groban, E. S., Narayanan, A. & Jacobson, M. P. Conformational changes in protein loops and helices induced by post-translational phosphorylation. PLoS Comput. Biol. 2, e32 (2006).
44. Banavali, N. K. & Roux, B. Anatomy of a structural pathway for activation of the catalytic domain of Src kinase Hck. Proteins 67, 1096-1112 (2007). (Pubitemid 46753954)
45. Gruszczynski, P., Obuchowski, M. & Kazmierkiewicz, R. Phosphorylation and ATP-binding induced conformational changes in the PrkC, Ser/Thr kinase from B. subtilis. J. Comput. Aided. Mol. Des. 24, 733-747 (2010).
46. Shan, Y., Arkhipov, A., Kim, E. T., Pan, A. C. & Shaw, D. E. Transitions to catalytically inactive conformations in EGFR kinase. Proc. Natl. Acad. Sci. U. S. A. 110, 7270-7275 (2013).
47. Steichen, J. M. et al. Global consequences of activation loop phosphorylation on protein kinase A. J. Biol. Chem. 285, 3825-3832 (2010).
48. Johnson, L. N., Noble, M. E. & Owen, D. J. Active and inactive protein kinases: structural basis for regulation. Cell 85, 149-158 (1996). (Pubitemid 26118158)
49. Hubbard, S. R.,Mohammadi, M.,Schlessinger, J. Autoregulatory mechanisms in protein-tyrosine kinases. J. Biol. Chem. 273, 11987-11990 (1998). (Pubitemid 28240552)
50. Knighton, D. R. et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 407-414 (1991). (Pubitemid 21917165)
51. Russo, A. A., Jeffrey, P. D. & Pavletich, N. P. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat. Struct. Biol. 3, 696-700 (1996). (Pubitemid 26260060)
52. Krupa, A., Preethi, G. & Srinivasan, N. Structural modes of stabilization of permissive phosphorylation sites in protein kinases: distinct strategies in Ser/Thr and Tyr kinases. J. Mol. Biol. 339, 1025-1039 (2004). (Pubitemid 39303246)
53. Cheng, S. & Niv, M. Y. Molecular dynamics simulations and elastic network analysis of protein kinase B (Akt/PKB) inactivation. J. Chem. Inf. Model. 50, 1602-1610 (2010).
54. Jeffrey, P. D. et al. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376, 313-320 (1995).
55. Huse, M. & Kuriyan, J. The conformational plasticity of protein kinases. Cell 109, 275-282 (2002). (Pubitemid 34606870)
56. Kornev, A. P., Haste, N. M., Taylor, S. S. ,Eyck, L. F. Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism. Proc. Natl. Acad. Sci. U. S. A. 103, 17783-17788 (2006). (Pubitemid 44852237)
57. Adams, J. A. Kinetic and catalytic mechanisms of protein kinases. Chem. Rev. 101, 2271-2290 (2001). (Pubitemid 35373019)
58. Gibbs, C. S. & Zoller, M. J. Rational scanning mutagenesis of a protein kinase identifies functional regions involved in catalysis and substrate interactions. J. Biol. Chem. 266, 8923-8931 (1991). (Pubitemid 21906599)
59. Madhusudan Akamine, P., Xuong, N. H. & Taylor, S. S. Crystal structure of a transition state mimic of the catalytic subunit of cAMP-dependent protein kinase. Nat. Struct. Biol. 9, 273-277 (2002). (Pubitemid 34289899)
60. Cheng, Y., Zhang, Y. & McCammon, J. A. How does activation loop phosphorylation modulate catalytic activity in the cAMP-dependent protein kinase: A theoretical study. Protein Sci. 15, 672-683 (2006).
61. Jura, N. et al. Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms. Mol. Cell 42, 9-22 (2011).
62. Taylor, S. S. & Kornev, A. P. Protein kinases: Evolution of dynamic regulatory proteins. Trends Biochem. Sci. 36, 65-77 (2011).
63. Picard, C., Casanova, J. L. & Puel, A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IkappaBalpha deficiency. Clin. Microbiol. Rev. 24, 490-497 (2011).
64. Lerner, E. C. et al. Activation of the Src family kinase Hck without SH3-linker release. J. Biol. Chem. 280, 40832-40837 (2005). (Pubitemid 41780575)
65. Moarefi, I. et al. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385, 650-653 (1997). (Pubitemid 27087580)
66. Samaddar, S. et al. Autophosphorylation of gatekeeper tyrosine by symbiosis receptor kinase. FEBS Lett. 587, 2972-2979 (2013).
67. Klaus-Heisen, D. et al. Structure-function similarities between a plant receptorlike kinase and the human interleukin-1 receptor-associated kinase-4. J. Biol. Chem. 286, 11202-11210 (2011).
68. Tamborini, E. et al. A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient. Gastroenterology 127, 294-299 (2004). (Pubitemid 38962296)
69. Lei, M., Robinson, M. A. & Harrison, S. C. The active conformation of the PAK1 kinase domain. Structure 13, 769-778 (2005). (Pubitemid 40704665)
70. Hekmat-Nejad, M., Cai, T. & Swinney, D. C. Steady-state kinetic characterization of kinase activity and requirements for Mg21of interleukin-1 receptor-associated kinase-4. Biochemistry 49, 1495-1506 (2010).
71. Yu, L. et al. Role of Mg21 ions in protein kinase phosphorylation: insights from molecular dynamics simulations of ATP-kinase complexes. Molecular Simulation 37, 1143-1150 (2011).
72. Keshwani, M. M. et al. Cotranslational cis-phosphorylation of the COOHterminal tail is a key priming step in the maturation of cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 109, E1221-1229 (2012).
73. Berendsen, H. J. C., van der Spoel, D. & van Drunen, R. GROMACS: A messagepassing parallel molecular dynamics implementation. Comput. Phys. Commun. 91, 43-56 (1995).
74. Hess, B.,Kutzner,C., van der Spoel, D.,Lindahl, E.GROMACS4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J. Chem. Theory Comput. 4, 435-447 (2008).
75. Schuttelkopf, A. W. & van Aalten, D. M. PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 60, 1355-1363 (2004). (Pubitemid 41079731)
76. Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: An N [center-dot] log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089-10092 (1993).
77. Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463-1472 (1997). (Pubitemid 127637344)
78. Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004).
79. Humphrey, W.,Dalke, A.,Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33-38, 27-38 (1996). (Pubitemid 26152973)
80. Amadei, A., Linssen, A. B. & Berendsen, H. J. Essential dynamics of proteins. Proteins 17, 412-425 (1993). (Pubitemid 23358549)
81. Yamaguchi, H., van Aalten, D. M., Pinak, M., Furukawa, A. ,Osman, R. Essential dynamics of DNA containing a cis.syn cyclobutane thymine dimer lesion. Nucleic Acids Res. 26, 1939-1946 (1998). (Pubitemid 28291726)
82. van Aalten, D. M., Findlay, J. B., Amadei, A.,Berendsen,H. J. Essential dynamics of the cellular retinol-binding protein-evidence for ligand-induced conformational changes. Protein Eng. 8, 1129-1135 (1995). (Pubitemid 26066519)
83. Amadei, A., Linssen, A. B., deGroot, B. L., van Aalten, D. M.,Berendsen, H. J. An efficient method for sampling the essential subspace of proteins. J. Biomol. Struct. Dyn. 13, 615-625 (1996). (Pubitemid 26081108)